A Phase II Open Label Study to Assess the Efficacy and Safety of Gemcitabine & Nab-Paclitaxel (Abraxane With or Without OSHD (2-0, 3-0 Desulfated Heparin) as First Line Treatment of Metastatic Pancreatic Cancer

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date3/1/122/28/14

    Funding

    • ParinGenix Incorporated: $9,378.00